Incyte Corporation (INCY) Share Price Rose While Baker Bros Advisors LP Has Upped Its Holding

March 14, 2018 - By Henry Gaston

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.02, from 1.02 in 2017Q2. It is positive, as 39 investors sold INCY shares while 161 reduced holdings. 59 funds opened positions while 149 raised stakes. 188.97 million shares or 2.28% more from 184.77 million shares in 2017Q2 were reported. 2,400 were reported by Gamco Investors Et Al. Moreover, Peak6 Ltd Partnership has 0.04% invested in Incyte Corporation (NASDAQ:INCY) for 64,105 shares. New York-based Jane Street Grp Lc has invested 0.01% in Incyte Corporation (NASDAQ:INCY). 796,242 were accumulated by Wells Fargo And Mn. Envestnet Asset Mgmt holds 0% or 5,850 shares in its portfolio. Fifth Third Fincl Bank, a Ohio-based fund reported 270 shares. Thomas J Herzfeld Advsrs Inc owns 242 shares. Ledyard Retail Bank holds 0% or 16 shares. The Germany-based Commerzbank Aktiengesellschaft Fi has invested 0.04% in Incyte Corporation (NASDAQ:INCY). Winfield Assoc has 100 shares. Gulf Intll Fincl Bank (Uk) has invested 0.09% in Incyte Corporation (NASDAQ:INCY). Ubs Asset Mgmt Americas stated it has 0.11% in Incyte Corporation (NASDAQ:INCY). Tourbillon Prtn LP has 255,000 shares for 0.72% of their portfolio. Norinchukin Bancorporation The accumulated 12,708 shares. Etrade Mngmt Limited Liability owns 2,345 shares.

Since September 18, 2017, it had 0 insider purchases, and 4 sales for $9.42 million activity. 1,958 shares valued at $167,507 were sold by Huber Reid M on Tuesday, February 20. Another trade for 70,502 shares valued at $8.42 million was sold by Hoppenot Herve.

Julian Baker increased its stake in Incyte Corporation (INCY) by 0.29% based on its latest 2017Q3 regulatory filing with the SEC. Baker Bros Advisors Lp bought 100,162 shares as the company’s stock rose 9.08% with the market. The hedge fund run by Julian Baker held 34.23M shares of the commercial physical & biological resarch company at the end of 2017Q3, valued at $4.00B, up from 34.13 million at the end of the previous reported quarter. Baker Bros Advisors Lp who had been investing in Incyte Corporation for a number of months, seems to be bullish on the $19.69B market cap company. The stock decreased 1.68% or $1.591 during the last trading session, reaching $93.039. About 1.88M shares traded or 12.27% up from the average. Incyte Corporation (NASDAQ:INCY) has risen 72.84% since March 14, 2017 and is uptrending. It has outperformed by 56.14% the S&P500.

More news for Incyte Corporation (NASDAQ:INCY) were recently published by:, which released: “Barclays bullish on Incyte, says market ignoring pipeline value” on February 16, 2018.‘s article titled: “Why Incyte (INCY) Might Surprise This Earnings Season February 14, 2018” and published on February 14, 2018 is yet another important article.

Incyte Corporation (NASDAQ:INCY) Ratings Coverage

Among 24 analysts covering Incyte (NASDAQ:INCY), 20 have Buy rating, 0 Sell and 4 Hold. Therefore 83% are positive. Incyte had 78 analyst reports since August 6, 2015 according to SRatingsIntel. J.P. Morgan maintained the shares of INCY in report on Tuesday, August 1 with “Buy” rating. The firm has “Buy” rating given on Wednesday, November 4 by UBS. BMO Capital Markets maintained Incyte Corporation (NASDAQ:INCY) rating on Monday, September 11. BMO Capital Markets has “Buy” rating and $163.0 target. As per Thursday, August 13, the company rating was initiated by Barclays Capital. The company was maintained on Thursday, November 12 by Leerink Swann. On Thursday, February 15 the stock rating was maintained by RBC Capital Markets with “Buy”. Cowen & Co maintained the shares of INCY in report on Tuesday, August 18 with “Outperform” rating. The stock of Incyte Corporation (NASDAQ:INCY) earned “Buy” rating by BMO Capital Markets on Thursday, February 15. Cowen & Co maintained the stock with “Buy” rating in Sunday, June 4 report. On Wednesday, October 12 the stock rating was maintained by RBC Capital Markets with “Outperform”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: